Some Items of Interest to Process R&D Chemists and Engineers

Robert Ely, John Knight(Memorial University of Newfoundland), Arjun Raghuraman(Dow Chemical (United States)), Andrei Zlota(University of Alaska Fairbanks), Paul Richardson(Pfizer (United States)), Robert B. Kargbo(Usona Institute), Alan Steven(Chemopharma (Austria)), Christopher C. Nawrat(Merck & Co., Inc., Rahway, NJ, USA (United States))

Organic Process Research & Development

November 9, 2017

10.1021/acs.oprd.7b00338

Cited by 0

Related Papers

Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations

|Journal of Medicinal Chemistry|2014|587

Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib

|Journal of Medicinal Chemistry|2014|118

Practical Singly and Doubly Electrophilic Aminating Agents: A New, More Sustainable Platform for Carbon–Nitrogen Bond Formation

|Journal of the American Chemical Society|2017|90

Finding a Needle in a Haystack: Development of a Combinatorial Virtual Screening Approach for Identifying High Specificity Heparin/Heparan Sulfate Sequence(s)

|Journal of Medicinal Chemistry|2006|74

Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds

|Tetrahedron Letters|2007|74